1 |
factor Xa
(930 times)
|
Vascular Diseases (177 times)
|
TF (73 times) APTT (66 times) PT (66 times)
|
1987 Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.
|
2 |
anti-factor Xa
(20 times)
|
Pharmacology (5 times)
|
APTT (2 times) DIC (2 times) LMWHs (2 times)
|
1991 [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
|
3 |
factor Xa inhibitor
(5 times)
|
Vascular Diseases (2 times)
|
AF (2 times) DOAC (2 times) OAC (2 times)
|
2018 Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay.
|
4 |
factor X activated
(2 times)
|
Biochemistry (2 times)
|
---
|
2015 Spirulan from blue-green algae inhibits fibrin and blood clots: its potent antithrombotic effects.
|
5 |
anti-FXa
(1 time)
|
Hematology (1 time)
|
APTT (1 time) PT (1 time)
|
2014 Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents.
|
6 |
factor X in an activated form
(1 time)
|
Toxicology (1 time)
|
Notechis scutatus (1 time)
|
2019 Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
|
7 |
factor X variant
(1 time)
|
Hematology (1 time)
|
APTT (1 time) PC (1 time) PT (1 time)
|
2019 Evaluation of biomarkers for monitoring thrombogenic potential of FXaI16L.
|
8 |
factorVII-activated FX
(1 time)
|
Hematology (1 time)
|
TF (1 time) TFPI (1 time)
|
2013 Aptamer BAX499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein.
|
9 |
Fondaparinux, a selective antithrombin-dependent inhibitor of activated factor X
(1 time)
|
Hematology (1 time)
|
ETP (1 time) PRP (1 time)
|
2004 Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma.
|
10 |
form Xa
(1 time)
|
Allergy and Immunology (1 time)
|
FX (1 time)
|
2004 A flow cytometric method for determining the binding of coagulation factor X to monocytes in whole human blood.
|
11 |
FX activation
(1 time)
|
Hematology (1 time)
|
FXI (1 time) TFPI (1 time)
|
2015 Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.
|
12 |
FX and its active form
(1 time)
|
Cell Biology (1 time)
|
CAM (1 time) HUVEC (1 time) ISV (1 time)
|
2014 Independent anti-angiogenic capacities of coagulation factors X and Xa.
|